journal
Journals Expert Review of Anti-infectiv...

Expert Review of Anti-infective Therapy

https://read.qxmd.com/read/38288986/the-clinical-application-of-traditional-chinese-medicine-nricm101-in-hospitalized-patients-with-covid-19
#21
JOURNAL ARTICLE
Wen-Kuei Chang, Chieh-Jen Wang, Tung-Hu Tsai, Fang-Ju Sun, Chao-Hsien Chen, Kuan-Chih Kuo, Hsin-Pei Chung, Yen-Hsiang Tang, Yen-Ting Chen, Kuo-Lun Wu, Jou-Chun Wu, Chang-Yi Lin, Hai-Bo Zhang
BACKGROUND: The aim of this study was to assess the efficacy and safety of NRICM101 in hospitalized patients with COVID-19. RESEARCH DESIGN AND METHODS: We conducted a retrospective study from 20 April 2021 to 8 July 2021, and evaluated the safety and outcomes (mortality, hospital stay, mechanical ventilation, oxygen support, diarrhea, serum potassium) in COVID-19 patients. Propensity score matching at a 1:2 ratio was performed to reduce confounding factors. RESULTS: A total of 201 patients were analyzed...
January 30, 2024: Expert Review of Anti-infective Therapy
https://read.qxmd.com/read/38288681/biosimilars-as-antivirals-opportunities-and-challenges
#22
EDITORIAL
Anan S Jarab, Shrouq R Abu Heshmeh, Ahmad Z Al Meslamani
No abstract text is available yet for this article.
January 30, 2024: Expert Review of Anti-infective Therapy
https://read.qxmd.com/read/38284355/can-adverse-cardiac-events-of-the-covid-19-vaccine-exacerbate-preexisting-diseases
#23
JOURNAL ARTICLE
Mohammed S Razzaque
INTRODUCTION: SARS-CoV-2 infection and COVID-19 vaccination can both lead to serious cardiac conditions such as myocarditis, arrhythmia, acute myocardial infarction, and coagulopathy. Further studies are needed to better understand the risks and benefits of COVID-19 vaccination, and to determine the best course of action for individuals with preexisting heart conditions. AREAS COVERED: The current knowledge and challenges in understanding vaccine-associated heart issues concerning the COVID-19 pandemic are briefly summarized, highlighting similar cardiac conditions caused by either SARS-CoV-2 infection or COVID-19 vaccination and the potential clinical impacts...
January 29, 2024: Expert Review of Anti-infective Therapy
https://read.qxmd.com/read/38275276/metallo-beta-lactamases-mechanisms-treatment-challenges-and-future-prospects
#24
REVIEW
Johnny Zakhour, L'Emir Wassim El Ayoubi, Souha S Kanj
INTRODUCTION: Metallo-beta-lactamases (MBLs) are responsible for resistance to almost all beta-lactam antibiotics. Found predominantly in Gram-negative bacteria, they severely limit treatment options. Understanding the epidemiology, risk factors, treatment, and prevention of infections caused by MBL-producing organisms is essential to reduce their burden. AREAS COVERED: The origins and structure of MBLs are discussed. We describe the mechanisms of action that differentiate MBLs from other beta-lactamases...
January 26, 2024: Expert Review of Anti-infective Therapy
https://read.qxmd.com/read/38263904/healthcare-professionals-understanding-and-perception-of-drug-related-issues-linked-to-off-label-pharmacological-medications-used-for-covid-19
#25
JOURNAL ARTICLE
Muhammad Zeeshan Munir, Amer Hayat Khan, Tahir Mehmood Khan
BACKGROUND: To evaluate the opinions of healthcare workers regarding drug therapy problems linked to anti-infective medicines used for the treatment of COVID-19 infection in Pakistan. RESEARCH METHODOLOGY: This cross-sectional study was conducted from January to October 2022 using a self-administered questionnaire developed by the authors, having three sections: demographics, knowledge, and perception. The study was validated by research experts and pilot-tested on 30 subjects...
January 24, 2024: Expert Review of Anti-infective Therapy
https://read.qxmd.com/read/38258529/ceftazidime-avibactam-and-aztreonam-combination-for-carbapenem-resistant-enterobacterales-bloodstream-infections-with-presumed-metallo-%C3%AE-lactamase-production-a-systematic-review-and-meta-analysis
#26
REVIEW
Nitin Gupta, Carl Boodman, Parikshit Prayag, Abi Manesh, Tirlangi Praveen Kumar
INTRODUCTION: Carbapenem-resistant Enterobacterales (CRE) due to Metallo-β-lactamase (MBL) production are treated with either polymyxins or the novel combination of ceftazidime-avibactam and aztreonam (AA). This study aims to evaluate the 30-day mortality of AA in patients with BSI caused by MBL-CRE infections. METHODOLOGY: In this systematic review and meta-analysis, all articles up to June 2023 were screened using search terms like 'CRE', 'MBL', 'AA' and 'polymyxins'...
January 23, 2024: Expert Review of Anti-infective Therapy
https://read.qxmd.com/read/38251634/drug-recommendation-for-optimization-on-treatment-outcome-for-mdr-rr-tb-based-on-a-multi-center-large-scale-retrospective-cohort-study-in-china
#27
JOURNAL ARTICLE
Lin Fan, Ming Yang, Yu-Tong Han, Fei Ren, Hua Wang, Jin-Bao Ma, Guo-Hui Zhu, Yan-Jun Xiong, Xin-Xin Fan, Su-Xia Chen, Hao-Yu Wu, Wen-Wen Sun, Shao-Jun Zhang, Hui Ke, Xiao-Hong Cheng, Biao Xu, Yu Chen, Chang Chen
OBJECTIVE: With the change in drug-resistant pattern, MDR/RR-TB was faced with underlying changes in regimens. A multi-center, large-scale, retrospective study performed aims to provide a recommendation of drug selection on optimization of outcome for the patients. METHOD: The study was conducted in six TB-specialized hospitals in China. Patients were included from 2018-2021 and followed up throughout the treatment. Using a multivarariable and propensity score-matched logistic regression analysis, we evaluated associations between outcomes and drug use, as well as clinical characteritics...
January 22, 2024: Expert Review of Anti-infective Therapy
https://read.qxmd.com/read/38404258/letermovir-for-cytomegalovirus-infection-in-allogeneic-hematopoietic-stem-cell-transplantation-tips-and-notes-for-effective-use-in-clinical-practice
#28
REVIEW
Akihiro Ohmoto, Shigeo Fuji
INTRODUCTION: Cytomegalovirus (CMV) infection remains a major complication after allogeneic hematopoietic stem cell transplantation (allo-HSCT). While conventional antiviral agents such as ganciclovir can be used for CMV prophylaxis, toxicities such as myelosuppression are a major concern. AREA COVERED: This work aimed to summarize the latest information and practical issues regarding a new anti-CMV agent, letermovir (LET). EXPERT OPINION: LET inhibits CMV replication by binding to components of the DNA terminase complex...
April 2024: Expert Review of Anti-infective Therapy
https://read.qxmd.com/read/38236906/carbapenem-resistant-klebsiella-pneumoniae-the-role-of-plasmids-in-emergence-dissemination-and-evolution-of-a-major-clinical-challenge
#29
REVIEW
Vincenzo Di Pilato, Simona Pollini, Vivi Miriagou, Gian Maria Rossolini, Marco Maria D'Andrea
INTRODUCTION: Klebsiella pneumoniae is a major agent of healthcare-associated infections and a cause of some community-acquired infections, including severe bacteremic infections associated with metastatic abscesses in liver and other organs. Clinical relevance is compounded by its outstanding propensity to evolve antibiotic resistance. In particular, the emergence and dissemination of carbapenem resistance in K. pneumoniae has posed a major challenge due to the few residual treatment options, which have only recently been expanded by some new agents...
January 18, 2024: Expert Review of Anti-infective Therapy
https://read.qxmd.com/read/38224018/could-herpesviridae-be-the-cause-of-severe-acute-hepatitis-of-unknown-origin-in-children
#30
JOURNAL ARTICLE
Livia Melo Villar, Lucas Lima da Silva, Barbara Vieira Do Lago, Jessica Gonçalves Pereira, Ana Carolina Silva Guimarães, Francisco Campello Do Amaral Mello, Vanessa Salete de Paula
INTRODUCTION: Severe acute hepatitis (SAH) is defined by a severe inflammation of hepatocytes in the liver parenchyma which can lead to an acute liver failure, a clinical condition with high mortality rate that can be triggered by several factors but is usually associated to hepatotropic viruses' infection. In 2022, cases of children with severe acute hepatitis of unknown origin hospitalized in Glasgow, Scotland, were reported. Possible causes of this condition include, but are not limited to, undiagnosed viral (and non-viral) infections, autoimmune hepatitis, drug and/or chemical toxicity, mitochondrial chain respiratory and metabolic disorders...
January 15, 2024: Expert Review of Anti-infective Therapy
https://read.qxmd.com/read/38217395/phage-therapy-resurrecting-a-historical-solution-for-the-contemporary-challenge-of-rising-antibiotic-resistance-in-latin-america
#31
JOURNAL ARTICLE
Justin Yeager, Ana María Gómez-Jaramillo, Esteban Ortiz-Prado, Manuel Calvopiña, Benjamin K Chan
INTRODUCTION: Antimicrobial resistance in Latin America is a growing concern in both human and non-human animal populations. The economic burden that is likely to be imposed through increased resistance will cause further strains on public health systems and the population at large. AREAS COVERED: We propose the rapid adoption and implementation of phage therapy as a necessary addition to the medical arsenal to help mitigate antimicrobial resistance, with an emphasis on considering the potential benefits that highly biodiverse countries such as Ecuador may have on phage discovery...
January 13, 2024: Expert Review of Anti-infective Therapy
https://read.qxmd.com/read/38193480/waking-up-to-the-naegleria-threat-urgent-measures-needed-to-protect-public-health-in-pakistan
#32
EDITORIAL
Ifrah Ata, Nabeel Riaz, Fariah Ata, Umer Farooq, Tauqeer Hussain Mallhi
No abstract text is available yet for this article.
January 9, 2024: Expert Review of Anti-infective Therapy
https://read.qxmd.com/read/38189087/predictors-and-patterns-of-empirical-antibiotic-therapy-and-associated-outcomes-in-covid-19-patients-a-retrospective-study-in-a-tertiary-care-facility-in-south-india
#33
JOURNAL ARTICLE
Lipin Lukose, Gursimran Kaur, Mohammed Asif M, Gail Ann Abraham, Kanav Khera, Subeesh K Viswam, Ronald L Castelino, Shubhada Karanth, Chandrashekar Udyavara Kudru, Muralidhar Varma, Sonal Sekhar Miraj
BACKGROUND: The coronavirus disease (COVID-19) led to a global health crisis, especially affecting low- and middle-income countries like India. Inappropriate use of antibiotics in COVID-19 patients has been a concern, leading to increased healthcare costs, adverse events, and antimicrobial resistance. This study evaluated the patterns and predictors of empirical antibiotic therapy in COVID-19 patients and associated outcomes. RESEARCH DESIGN AND METHODS: A hospital-based retrospective, observational study was conducted with 525 patients admitted to Kasturba Hospital, Manipal, India, with moderate and severe COVID-19 from 1st March to NaN Invalid Date ...
January 8, 2024: Expert Review of Anti-infective Therapy
https://read.qxmd.com/read/38180805/understanding-staphylococcus-aureus-internalization-and-induction-of-antimicrobial-tolerance
#34
REVIEW
Frédéric Goormaghtigh, Françoise Van Bambeke
INTRODUCTION: Staphylococcus aureus , a human commensal, is also one of the most common and serious pathogens for humans. In recent years, its capacity to survive and replicate in phagocytic and non-phagocytic cells has been largely demonstrated. In these intracellular niches, bacteria are shielded from the immune response and antibiotics, turning host cells into long-term infectious reservoirs. Moreover, neutrophils carry intracellular bacteria in the bloodstream, leading to systemic spreading of the disease...
January 5, 2024: Expert Review of Anti-infective Therapy
https://read.qxmd.com/read/38178687/the-clinical-outcomes-and-effectiveness-of-antiviral-agents-among-underweight-patients-with-covid-19
#35
JOURNAL ARTICLE
Jheng-Yan Wu, Mei-Yuan Liu, Mei-Chuan Lee, Kuo-Chuan Hung, Wan-Hsuan Hsu, Ya-Wen Tsai, Ting-Hui Liu, Po-Yu Huang, Min-Hsiang Chuang, Shu-Ching Tseng, Chih-Ying Lu, Chih-Cheng Lai
OBJECTIVES: This study investigated the outcomes ofunderweight patients with COVID-19 and the effectiveness of antiviral agents inthis population. METHODS: A retrospective cohort study using theTriNetX research network wasconducted. Propensity score matching (PSM) was employed to balance the firstcohort involving COVID-19 patients with underweight and normal-weight. In thesecond cohort, underweight patients receiving antiviral agents and untreatedindividuals were matched using PSM...
January 4, 2024: Expert Review of Anti-infective Therapy
https://read.qxmd.com/read/38183224/reviewing-novel-treatment-options-for-carbapenem-resistant-enterobacterales
#36
REVIEW
Natalie A Mackow, David van Duin
INTRODUCTION: Carbapenem resistant Enterobacterales (CRE) are a major threat to global health and hospital-onset CRE infections have risen during the COVID-19 pandemic. Novel antimicrobials are now available for the treatment of CRE infections. There remains an urgent need for new antimicrobials for CRE, especially for those producing metallo-β-lactamases. AREAS COVERED: This article discusses previously published research supporting currently available novel antimicrobials for the treatment of CRE infections...
2024: Expert Review of Anti-infective Therapy
https://read.qxmd.com/read/38146949/bacterial-co-infections-secondary-infections-and-antimicrobial-use-among-hospitalized-covid-19-patients-in-the-sixth-wave-in-pakistan-findings-and-implications
#37
JOURNAL ARTICLE
Zia Ul Mustafa, Arfa Batool, Hadia Ibrar, Muhammad Salman, Yusra Habib Khan, Tauqeer Hussain Malhi, Johanna C Meyer, Brian Godman, Catrin E Moore
INTRODUCTION: Previous studies in Pakistan have shown considerable over prescribing of antibiotics in patients hospitalized with COVID-19 despite very low prevalence of bacterial infections. Irrational use of antibiotics will worsen antimicrobial resistance (AMR). METHODS: Retrospective analysis of medical records of patients in the COVID-19 wards of three tertiary care hospitals to assess antibiotic use during the sixth COVID-19 wave. RESULTS: 284 patients were included, most were male (66...
December 26, 2023: Expert Review of Anti-infective Therapy
https://read.qxmd.com/read/38112181/clinical-utility-of-procalcitonin-in-implementation-of-procalcitonin-guided-antibiotic-stewardship-in-the-south-east-asia-and-india-evidence-and-consensus-based-recommendations
#38
REVIEW
Andrea Lay-Hoon Kwa, Brigitte Rina Aninda Sidharta, Do Ngoc Son, Kapil Zirpe, Petrick Periyasamy, Rongpong Plongla, Subramanian Swaminathan, Tonny Loho, Vu Van Giap, Anucha Apisarnthanarak
INTRODUCTION: The South-East Asian (SEA) region and India are highly susceptible to antibiotic resistance, which is caused due to lack of antimicrobial stewardship (AMS) knowledge, uncontrolled use of antibiotics, and poor infection control. Nonadherence to national/local guidelines, developed to combat antimicrobial resistance, is a major concern. A virtual advisory board was conducted to understand the current AMS standards and challenges in its implementation in these regions. AREAS COVERED: Procalcitonin (PCT)-guided antibiotic use was discussed in various clinical conditions across initiation, management, and discontinuation stages...
December 19, 2023: Expert Review of Anti-infective Therapy
https://read.qxmd.com/read/38098185/low-risk-penicillin-allergy-delabeling-a-scoping-review-of-direct-oral-challenge-practice-implementation-and-multi-disciplinary-approaches
#39
REVIEW
Elise Mitri, Gemma Reynolds, Catherine J Hornung, Jason A Trubiano
INTRODUCTION: Penicillin allergy is common, and there is increased clinician interest in direct oral challenge (DOC) as a testing strategy for low-risk penicillin allergy. To aid wider implementation of DOC, consensus definitions of low-risk penicillin allergy phenotypes, and standardized approaches to assessment, DOC procedures, and evaluation, are required. AREAS COVERED: This review systematically reviews studies that have utilized penicillin DOC in healthcare settings to identify heterogeneity in implementation approaches and synthesize low-risk definitions, procedures, and evaluation...
December 14, 2023: Expert Review of Anti-infective Therapy
https://read.qxmd.com/read/38097501/immunocompromised-patients-and-covid-19-how-do-we-protect-those-most-at-risk
#40
EDITORIAL
Jochen Schneider, Johanna Erber, Lutz Renders, Christoph D Spinner
No abstract text is available yet for this article.
December 14, 2023: Expert Review of Anti-infective Therapy
journal
journal
40471
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.